{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34262151",
  "DateCompleted": {
    "Year": "2021",
    "Month": "12",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "02",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41416-021-01489-5"
    ],
    "Journal": {
      "ISSN": "1532-1827",
      "JournalIssue": {
        "Volume": "125",
        "Issue": "10",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov"
        }
      },
      "Title": "British journal of cancer",
      "ISOAbbreviation": "Br J Cancer"
    },
    "ArticleTitle": "Can exercise prevent the onset of chemotherapy-induced peripheral neuropathy?",
    "Pagination": {
      "StartPage": "1319",
      "EndPage": "1320",
      "MedlinePgn": "1319-1320"
    },
    "Abstract": {
      "AbstractText": [
        "To date, there are no effective interventions to prevent the onset and severity of chemotherapy-induced peripheral neuropathy (CIPN). Exercising during chemotherapy treatment has displayed a range of clinical benefits, yet only limited published studies have investigated whether exercise is protective against preventing CIPN. This Editorial discusses a randomised control study of the efficacy of strength or balance exercise to prevent CIPN."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer Nature Limited."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-1174-2248"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. d.mizrahi@unsw.edu.au."
          }
        ],
        "LastName": "Mizrahi",
        "ForeName": "David",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Cancer",
    "NlmUniqueID": "0370635",
    "ISSNLinking": "0007-0920"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemically induced",
        "prevention & control"
      ],
      "DescriptorName": "Peripheral Nervous System Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Postural Balance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quality of Life"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Resistance Training"
    }
  ],
  "CoiStatement": "The author declares no competing interests. He declares that he was one of three reviewers for this publication."
}